All articles tagged with #brain disorders
The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for developing optogenetics. This technique uses light to activate or inhibit specific neurons in living brains, enabling precise study of neural circuits. The discovery, rooted in algae-derived proteins, offers new pathways for treating conditions like blindness, depression, and Parkinson’s disease.
Recent research reveals that fMRI signals often misrepresent actual neural activity, with about 40% of cases showing increased signals where neural activity is reduced, due to regions extracting more oxygen without increased blood flow. This challenges long-standing assumptions in brain imaging and suggests a need for direct energy consumption measurements to better understand brain function and disorders.
Research from the University of Oslo reveals extensive genetic links between neurological and psychiatric disorders, challenging traditional distinctions and suggesting a more integrated approach to treatment and understanding of brain conditions.
A new study suggests that nanobodies, small antibody-like proteins found in camelids like alpacas, could be developed into treatments for brain disorders such as Alzheimer's, offering potential advantages over traditional antibodies due to their size and ability to passively enter the brain, though further safety and efficacy testing is needed before clinical trials.
Two leading neurologists suggest that Parkinson's disease, the fastest growing brain disorder, may be entirely preventable through early intervention and lifestyle changes, as discussed in the 'In Good Health' series.
New research demonstrates that synaptic connections in the cerebral cortex can strengthen during sleep under specific neural activity conditions, supporting the possibility of sleep-based learning and offering insights into sleep-related brain disorders and memory improvement strategies.
New research suggests that blocking kappa opioid receptors (KOR) can restore normal dopamine signaling in mouse models with a rare mutation, offering a potential safer treatment for disorders like ADHD, autism, and bipolar disorder by targeting dopamine imbalances without the side effects of current therapies.
Scientists have used Deep Brain Stimulation (DBS) to identify dysfunctional brain circuits responsible for Parkinson's, Tourette's syndrome, OCD, and dystonia, offering a potential path to target the sources of these common brain disorders. This breakthrough could lead to the development of cures or better medications to alleviate symptoms. Additionally, a new gene change in a microprotein called SHLP2 has been discovered, which protects against Parkinson's and could lead to new treatments, offering hope for precision medicine-based therapies for these devastating diseases.
Scientists at Mass General Brigham have identified the sources of Parkinson’s, Tourette’s syndrome, OCD, and dystonia in a groundbreaking study using Deep Brain Stimulation (DBS) to pinpoint dysfunctions in the brain responsible for these disorders. By lighting up parts of the brain and using electrodes, they were able to identify malfunctioning networks and understand why DBS has been helping patients. This breakthrough could lead to the development of better remedies and medications for these common brain disorders, offering hope for potential cures in the future. Additionally, a previously unknown genetic mutation that provides significant protection against Parkinson's has been identified, potentially leading to new medical treatments for the condition.
Researchers at Mass General Brigham have used deep brain stimulation (DBS) to identify dysfunctional brain circuits responsible for Parkinson’s disease, dystonia, obsessive compulsive disorder (OCD), and Tourette's syndrome, potentially leading to new treatments. The study, published in Nature Neuroscience, involved 261 patients and showed preliminary improved results in three cases. While the findings provide hope for personalized therapies, experts caution that the study's small sample size requires further validation through prospective trials. The research marks the first step in defining the "human dysfunctome," and may lead to more sophisticated mapping techniques and new therapeutic avenues for neurological conditions.
A new non-invasive brain stimulation technique called Patterned Low-Intensity Low-Frequency Ultrasound (LILFUS) has been developed by researchers, showing promise for treating brain disorders. This technique, which uses ultrasound to stimulate specific brain areas, has the potential to induce long-lasting changes in brain function by modulating neural plasticity. The study found that LILFUS can improve motor skill learning and may have applications in treating conditions such as depression. The researchers plan to continue studying the technology for the treatment of brain disorders and the enhancement of cognitive functions.
A large vaccine study found that COVID vaccines from Pfizer, Moderna, and AstraZeneca are linked to rare occurrences of heart, brain, and blood disorders, including myocarditis, pericarditis, blood clots in the brain, Guillain-Barre syndrome, and other conditions. While the study identified increased risks, experts emphasize that the benefits of vaccination still outweigh the risks, especially compared to the potential risks of contracting COVID-19.
Researchers have created the first comprehensive cell atlas of a mammalian brain, mapping over 32 million cells in the mouse brain. This atlas, part of the NIH BRAIN Initiative, offers unprecedented insights into brain cell types and connections, advancing our understanding of the human brain and aiding in developing new treatments for brain disorders.
A groundbreaking study conducted by researchers at Vanderbilt University has used functional magnetic resonance imaging (fMRI) to detect significant brain activity in white matter, challenging the conventional focus on gray matter. The study observed increased blood oxygenation-level dependent (BOLD) signals in white matter when subjects performed tasks, suggesting the potential importance of white matter in understanding various brain disorders. The researchers aim to further investigate these white matter signals and their biological basis, as well as their implications for brain function and connectivity.
Scientists at Vanderbilt University have used functional magnetic resonance imaging (fMRI) to detect blood oxygenation-level dependent (BOLD) signals in the white matter of the brain. They found that when individuals performed tasks during brain scans, BOLD signals increased in white matter throughout the brain. This discovery challenges the historical focus on gray matter and suggests that white matter plays a significant role in brain activity. Further research will explore the implications for brain disorders and investigate the biological basis for these changes.